Navigation Links
In Elderly Patients Lowering Contrast Material Injection Will Reduce Costs

A new study says that in elderly patients who are undergoing multi-detector CT examination of the pancreas and biliary region, doctors may safely reduce the dose of a contrast agent by 10 percent. // Doing this will reduce the costs as well as the risks associated with the tests, according to the study. The Department of Technical Radiology at Nagoya University School of Health Science in Nagoya, Japan undertook this study.

"When interpreting CT images acquired using the established protocol in our clinical practice, it was noted that in some examinations of elderly patients, contrast enhancement of the pancreatic parenchyma was too intense," said Shigeki Itoh, MD, lead author of the study. "Therefore, we speculated that it might be possible to reduce the dose and rate of contrast material injection without adversely affecting the degree of contrast enhancement in elderly patients," said Dr. Itoh.

The study included 112 patients, ranging from 23-80 years old who had known or suspected pancreatobiliary disease who were split into three groups (60 years old or younger with a contrast injection of 0.08 milliliters/kg/sec, 60 years old or older with a contrast injection of 0.08 milliliters/kg/sec, and 60 years old or older with a contrast injection of 0.07 milliliters/kg/sec).

Group 3 had a 12.2% reduction in the volume and rate of contrast material injection. According to previous studies, contrast enhancement in the vessels and the organs of the abdomen increases with an increase in the volume and rate of contrast material injection. However, Dr. Itoh said that this wasn't the case in his study. Dr. Itoh noted it is essential to administer contrast material only at the volume and rate needed to achieve an adequate level of contrast enhancement for diagnosis.

Source-Eurekalert
RAS
'"/>




Page: 1

Related medicine news :

1. More Elderly Take Inappropriate and Harmful Medications
2. Depression Weighs Heaviest on the Elderly
3. Chronic Diseases said to Cause Falls in the Elderly
4. Depression a cause for Death in Elderly
5. Elderly Women With Depression More Prone to Heart Disease
6. Depression in Elderly
7. Elderly Women With Depression More Prone to Heart Disease
8. Radiation Therapy for Prostate Cancer Tolerated Well by Elderly Patients
9. Depression Found To Be A Major Cause for Death in Elderly
10. Risky Drugs To Be Avoided In The Elderly
11. The Options For Relieving Chest Pain In the Elderly Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie ... on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East Side, ... such as Zen Kodo mat. Wanderlust , one of the largest US yoga ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... of the Month, Lewis and Clark College Emeritus Professor of Education Gregory A. ... Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of providing a voice for people who have kidney disease. The theme “Describe ... to share their stories. Entrants needed to meet only one qualification— to ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... the Orthodontics and Clear Aligner clinical and commercial support services market) has entered ... Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first private ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: